Skip to main content
Premium Trial:

Request an Annual Quote

Douglas Amorese, Lee Hood, Trevor Hawkins

Premium
Douglas Amorese has become vice president of research and development at NuGen Technologies, a new position, the DNA amplification and labeling company said this week. Most recently, he was director of research and development for Agilent Technologies' genomics group, where he was responsible for new product development projects related to the company's DNA microarray business. Prior to that, he held various positions at DuPont and Life Technologies. Amorese holds a PhD in biochemistry from Colorado State University.
 

 
Lee Hood has joined the advisory committee of venture capital firm InterWest Partners, the company said this week. He had already been a member of InterWest’s life sciences advisory committee. Hood is president and co-founder of the Institute for Systems Biology.
 

 
Trevor Hawkins has become chairman and CEO of ProGenTech, the company said last week. Previously, he was CEO of Philips Molecular Healthcare and held executive positions at GE and at MDS. Hawkins is also the former director of the US Department of Energy’s Joint Genome Institute.

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Sanction Violation Charges

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.